BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30279248)

  • 1. Olmesartan-induced enteropathy.
    Onteddu NK; Pulivarthi VSKK; Ginnavaram M; Kedika R
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30279248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olmesartan-Induced Enteropathy.
    Adike A; Corral J; Rybnicek D; Sussman D; Shah S; Quigley E
    Methodist Debakey Cardiovasc J; 2016; 12(4):230-232. PubMed ID: 28289500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An atypical case of chronic diarrhoea: olmesartan-induced sprue-like enteropathy.
    Naik DK; Martelli MG; Gonzalo DH; Sharma AK; Pannu D
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26370634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Olmesartan-associated enteropathy: attention to an emerging iatrogenic phenomenon].
    Modesto Dos Santos JL; González Recio P; Terry López OA; Leturia Frade I; Aguiar Losada B; Elejalde Guerra JI
    An Sist Sanit Navar; 2017 Aug; 40(2):291-294. PubMed ID: 28676728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss.
    Gonakoti S; Khullar S; Rajkumar A
    Am J Case Rep; 2019 Jan; 20():111-116. PubMed ID: 30683835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diarrhoea and malabsorption due to olmesartan use].
    van Beurden YH; Nijeboer P; Janssen J; Verbeek WH; Mulder CJ
    Ned Tijdschr Geneeskd; 2014; 158():A7370. PubMed ID: 24780574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Three cases of severe chronic diarrhea with a rare cause and a simple therapy].
    Rommel KP; Schneider E; Witschel I; Halm U; Zachäus M
    Internist (Berl); 2018 Sep; 59(9):961-966. PubMed ID: 29637237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature.
    Kulai T; Arnason T; MacIntosh D; Igoe J
    Can J Gastroenterol Hepatol; 2016; 2016():6091571. PubMed ID: 27446852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olmesartan: sprue-like enteropathy.
    Prescrire Int; 2014 Apr; 23(148):102. PubMed ID: 24860900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.
    Choi EY; McKenna BJ
    Arch Pathol Lab Med; 2015 Oct; 139(10):1242-7. PubMed ID: 26414468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An unusual case of olmesartan induced enteropathy].
    Henry P; Dano H; Piessevaux H; Jouret-Mourin A
    Ann Pathol; 2019 Jun; 39(3):237-240. PubMed ID: 30712983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic diarrhoea, weight loss and a positive anti-tissue transglutaminase antibody: A case report of olmesartan-induced enteropathy.
    Sheppard R; Evanson B; Campbell I; Shand A
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38719261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical-Pathological Conference Series from the Medical University of Graz: Case No 156: 82-year-old woman with chronic diarrhea and weight loss of 20 kilograms.
    Fabian E; Schiller D; Wenzl H; Lackner C; Donnerer J; Ziachehabi A; Silye R; Schöfl R; Krejs GJ
    Wien Klin Wochenschr; 2015 Dec; 127(23-24):974-80. PubMed ID: 26610650
    [No Abstract]   [Full Text] [Related]  

  • 14. Five cases of sprue-like enteropathy in patients treated by olmesartan.
    Théophile H; David XR; Miremont-Salamé G; Haramburu F
    Dig Liver Dis; 2014 May; 46(5):465-9. PubMed ID: 24472297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Olmesartan therapy and enteropathy: About two cases and review of the literature].
    Sadki A; Le Besnerais M; Héron F; Marie I
    Rev Med Interne; 2019 Feb; 40(2):112-116. PubMed ID: 30174111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe spruelike enteropathy associated with olmesartan.
    Rubio-Tapia A; Herman ML; Ludvigsson JF; Kelly DG; Mangan TF; Wu TT; Murray JA
    Mayo Clin Proc; 2012 Aug; 87(8):732-8. PubMed ID: 22728033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant Weight Loss in a Patient Taking Olmesartan: An Unusual Case Report.
    Makri A; Florentin M; Elisaf MS; Liamis G
    Curr Drug Saf; 2019; 14(3):238-241. PubMed ID: 30848210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review: Sprue-like enteropathy associated with olmesartan.
    Ianiro G; Bibbò S; Montalto M; Ricci R; Gasbarrini A; Cammarota G
    Aliment Pharmacol Ther; 2014 Jul; 40(1):16-23. PubMed ID: 24805127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Severe enteropathy with villous atrophy olmesartan medoxomil-associated].
    Nunge D; Eoche M; Fumery M; Nguyen-Khac E; Gras V; Andréjak M
    Therapie; 2013; 68(6):419-21. PubMed ID: 24246126
    [No Abstract]   [Full Text] [Related]  

  • 20. Olmesartan-associated sprue-like enteropathy: An emerging cause of drug-induced chronic diarrhea.
    Solano-Iturri G; García-Jiménez N; Solano-Iturri JD; Blanco-Sampascual S
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(1):71-72. PubMed ID: 28291561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.